2017 – Analysis of Food and Drug Administration’s Office of Prescription Drug Promotion OPDP Enforcement Letters on Investigational New Drugs INDs from 1998 to 2017
2012 – How Do Priority And Orphan Status Designations Affect Review Times For New Oncology Indications Approved Through A Supplemental Application? A Retrospective Analysis